By Sam Chambers
Co. to test Neocore device with consumers after FDA approval
- BAT plans Alto, nicotine-salt product, to compete with Juul
BAT’s first-half profit of 4.82 billion pounds ($6.4 billion) was slightly ahead of analysts’ estimates. The London-based company said it received approval from the U.S. Food and Drug Administration to begin selling its Neocore heated-tobacco device, which was formerly known as Eclipse.